2017
DOI: 10.1371/journal.pone.0175710
|View full text |Cite
|
Sign up to set email alerts
|

Effect of quinoline based 1,2,3-triazole and its structural analogues on growth and virulence attributes of Candida albicans

Abstract: Candida albicans, along with some other non-albicans Candida species, is a group of yeast, which causes serious infections in humans that can be both systemic and superficial. Despite the fact that extensive efforts have been put into the discovery of novel antifungal agents, the frequency of these fungal infections has increased drastically worldwide. In our quest for the discovery of novel antifungal compounds, we had previously synthesized and screened quinoline containing 1,2,3-triazole (3a) as a potent Ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
30
0
2

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 34 publications
0
30
0
2
Order By: Relevance
“…Activated lansoprazole is a novel benzimidazole proton pump inhibitor, which assists in the inhibition of hyphal growth (Monk et al, 1995 ; Perlin et al, 1997 ; Biswas et al, 2001 ). Furthermore, NC1175 and 1,2,3-triazole 3a are synthetic compounds that exhibit inhibitory activity against C. albicans by restraining the acidification of external medium with an minimum inhibitory concentration (MIC) of 25 μg/mL (Manavathu et al, 1999 ; Irfan et al, 2017 ). Additionally, concanamycin A, the most commonly used V-ATPase inhibitor, displays antifungal properties especially against C. albicans , and the MIC of concanamycin A is 25 μg/mL (Okoli et al, 2009 ).…”
Section: H + Homeostasis and Potential Antifungal mentioning
confidence: 99%
“…Activated lansoprazole is a novel benzimidazole proton pump inhibitor, which assists in the inhibition of hyphal growth (Monk et al, 1995 ; Perlin et al, 1997 ; Biswas et al, 2001 ). Furthermore, NC1175 and 1,2,3-triazole 3a are synthetic compounds that exhibit inhibitory activity against C. albicans by restraining the acidification of external medium with an minimum inhibitory concentration (MIC) of 25 μg/mL (Manavathu et al, 1999 ; Irfan et al, 2017 ). Additionally, concanamycin A, the most commonly used V-ATPase inhibitor, displays antifungal properties especially against C. albicans , and the MIC of concanamycin A is 25 μg/mL (Okoli et al, 2009 ).…”
Section: H + Homeostasis and Potential Antifungal mentioning
confidence: 99%
“…A survey of literature pertaining to quinoline or quinolone antifungal agents revealed that some compounds exhibit fungistatic activity while other compounds exhibit fungicidal activity against C. albicans 23 . To investigate this matter further, compound 4b and the control antifungal drug 5-Fluorocytsine were examined against C. albicans in a time-kill assay (Figure 2).…”
Section: Resultsmentioning
confidence: 99%
“…20 To support this argument in case of azole drugs, we also determined the ergosterol content in the presence of our lead inhibitor 5n by sterol quantitation method in C. albicans ATCC 90028. 22,23 UV spectrophotometric sterol prole of C. albicans showed a dose-dependent sharp decrease in sterol content as shown in Fig. 6.…”
Section: Pharmacological Evaluationmentioning
confidence: 87%
“…The total intracellular sterols were extracted as reported earlier with slight modications. 22,23 50 mL of SD broth medium prepared in four conical asks, sterilized and inoculated with freshly cultured cells of C. albicans ATCC 90028. All conical asks were incubated at 30 C and 160 rpm for 3 hours.…”
Section: Biologymentioning
confidence: 99%